ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
폰다파리눅스 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 이 기간에 예상되는 주요 동향은 약물전달 시스템의 발전, 프리 필드 시린지 기술의 개발, AI 대응 파마 코비지 란스 시스템의 통합, 생합성 제조 공정, 웨어러블 약물전달 디바이스의 대두 등이 있습니다.
혈전 색전증의 이환율이 증가하는 것은 폰다파리눅스 시장 성장을 크게 촉진할 것으로 예측됩니다. 노인은 혈액 순환의 저하 및 기타 건강 관련 문제에 의해 심부정맥 혈전증이나 폐 색전증 등의 질환에 걸리기 쉬워지기 때문에 이러한 유병률 증가는 고령화 인구에 크게 기인하고 있습니다. 예를 들어, 2025년 1월 미국 질병 예방 관리 센터(CDC)는 정맥 혈전 색전증(VTE)에 의해 미국에서 연간 6만-10만명이 사망해 많은 사람이 장기간에 걸친 합병증에 시달리고 있다고 보고했습니다.
헬스케어 지출 증가가 폰다파리눅스 시장 성장을 가속할 것으로 예측됩니다. 이러한 건강 관리 지출 증가는 고급 치료 및 기술에 대한 수요 증가, 만성 질환의 만연 및 더 많은 건강 관리 서비스를 필요로 하는 노화로 인한 것입니다. 폰다파리눅스에 대한 수요가 증가함에 따라, 특히 심혈관 질환이나 혈전 색전증의 치료에 걸리는 의료비도 증가합니다. 예를 들어, 2024년 5월 영국 통계청은 2022년부터 2023년까지 의료비 지출이 5.6% 증가하여 2022년의 0.9% 성장률에 비해 급격히 증가했다고 발표했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 폰다파리눅스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 폰다파리눅스 시장 : 성장률 분석
세계의 폰다파리눅스 시장 실적 : 규모와 성장(2019-2024년)
세계의 폰다파리눅스 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 폰다파리눅스 전체 시장(TAM)
제6장 시장 세분화
세계의 폰다파리눅스 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
심부정맥 혈전증
폐색전증
세계의 폰다파리눅스 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
비경구
기타 투여 경로
세계의 폰다파리눅스 시장 : 제형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
주사
프리필드 주사기
세계의 폰다파리눅스 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 폰다파리눅스 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
기타 최종 사용자
세계의 폰다파리눅스 시장 : 심부정맥 혈전증 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
예방
치료(관리)
세계의 폰다파리눅스 시장 : 폐색전증 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
급성 폐색전증
만성 폐색전증 관리
제7장 지역별/국가별 분석
세계의 폰다파리눅스 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 폰다파리눅스 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
폰다파리눅스 시장 : 경쟁 구도
폰다파리눅스 시장 : 기업 프로파일
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
GlaxoSmithKline plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Viatris Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Mylan NV : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sandoz Group AG
Sun Pharmaceutical Industries Limited
Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Cipla Limited
Aurobindo Pharma Limited
Dr. Reddy's Laboratories Limited
Aspen Pharmacare Holdings Limited
Lupin Pharmaceuticals Inc.
Zydus Lifesciences Limited
Sihuan Pharmaceutical Holdings Group Ltd.
Hefei TNJ Chemical Industry Co. Ltd.
Apino Pharma Co. Ltd.
Home Sunshine Pharma Co. Ltd.
Alchemia Limited
Zhejiang Borui Pharmaceutical Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
폰다파리눅스 시장(2029년) : 새로운 기회를 제공하는 국가
폰다파리눅스 시장(2029년) : 새로운 기회를 제공하는 부문
폰다파리눅스 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Fondaparinux is a synthetic anticoagulant that works by selectively inhibiting Factor Xa, preventing the formation of blood clots. It is commonly used to reduce the risk of thromboembolic events in patients at risk.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main uses of fondaparinux include treating deep vein thrombosis (DVT) and pulmonary embolism. Deep vein thrombosis (DVT) is a condition in which a blood clot forms in a deep vein, usually in the legs, and can lead to serious complications if left untreated. Fondaparinux is typically administered through various routes, including parenteral methods such as injections and pre-filled syringes. It is available in different dosage forms, primarily injections. The drug is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies. Key end users include hospitals, specialty clinics, and other healthcare providers.
The fondaparinux market research report is one of a series of new reports from The Business Research Company that provides fondaparinux market statistics, including the fondaparinux industry global market size, regional shares, competitors with the fondaparinux market share, detailed fondaparinux market segments, market trends, and opportunities, and any further data you may need to thrive in the fondaparinux industry. This fondaparinux market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The fondaparinux market size has grown strongly in recent years. It will grow from$1.85 billion in 2024 to $2.00 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period can be attributed to the rising incidence of venous thromboembolism, an increase in surgical procedures, an aging population, global healthcare improvements, and the growing preference for injectable anticoagulants.
The fondaparinux market size is expected to see strong growth in the next few years. It will grow to$2.68 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth during the forecast period can be attributed to the growing prevalence of obesity, rising awareness of thrombosis prophylaxis, government support and reimbursement policies, and the increase in high-risk surgical procedures. Key trends expected in this period include advancements in drug delivery systems, the development of pre-filled syringe technology, the integration of AI-enabled pharmacovigilance systems, biosynthetic manufacturing processes, and the rise of wearable drug delivery devices.
The rising incidence of thromboembolic conditions is expected to significantly drive the growth of the fondaparinux market. Thromboembolic conditions occur when blood clots form in blood vessels and obstruct blood flow to vital parts of the body. This increase in prevalence is largely attributed to the aging population, as older individuals are more susceptible to conditions such as deep vein thrombosis and pulmonary embolism due to slower blood circulation and other health-related issues. Fondaparinux is used to prevent and treat these conditions by inhibiting the formation of harmful blood clots. For example, in January 2025, the Centers for Disease Control and Prevention (CDC) reported that 60,000 to 100,000 fatalities occur annually in the United States due to venous thromboembolism (VTE), with many individuals suffering from long-term complications. Thus, the rising prevalence of thromboembolic conditions will continue to drive the growth of the fondaparinux market.
Rising healthcare expenditures are expected to fuel the growth of the fondaparinux market. Healthcare expenditures refer to the total financial outlay for medical services, treatments, and healthcare-related products by individuals, governments, and organizations. These rising expenditures are driven by an increased demand for advanced medical treatments and technologies, as well as the growing prevalence of chronic diseases and an aging population requiring more healthcare services. As demand for fondaparinux increases, especially for treating cardiovascular and thromboembolic conditions, healthcare costs also rise. For instance, in May 2024, the Office for National Statistics in the UK reported a 5.6% increase in healthcare expenditure from 2022 to 2023, a sharp rise compared to the 0.9% growth seen in 2022. Therefore, increasing healthcare expenditures will propel the growth of the fondaparinux market.
Key players in the fondaparinux market are focusing on innovations such as pediatric-specific drug development to expand the therapeutic applications of fondaparinux, address unmet medical needs, and enhance treatment options for younger patients with conditions such as venous thromboembolism (VTE). Pediatric drug development involves creating and adjusting medications to ensure they are safe and effective for children, considering their unique physiological and developmental requirements. For example, in December 2024, Mylan N.V., a US-based pharmaceutical company, received approval from the Food and Drug Administration (FDA) for Arixtra in treating VTE in pediatric patients aged 1 year and older, weighing at least 10 kg. Arixtra is also approved for adult conditions, including the prevention of deep vein thrombosis (DVT) and the treatment of acute DVT and pulmonary embolism. The pediatric approval was supported by a retrospective, open-label clinical study involving 366 patients, which showed that 44.9% of participants experienced complete resolution of at least one clot, while 44% had full resolution of all clots.
Major players in the fondaparinux market are Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Viatris Inc., Mylan N.V., Sandoz Group AG, Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Pharmaceuticals Co. Ltd., Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Aspen Pharmacare Holdings Limited, Lupin Pharmaceuticals Inc., Zydus Lifesciences Limited, Sihuan Pharmaceutical Holdings Group Ltd., Hefei TNJ Chemical Industry Co. Ltd., Apino Pharma Co. Ltd., Home Sunshine Pharma Co. Ltd., Alchemia Limited, Zhejiang Borui Pharmaceutical Co. Ltd.
North America was the largest region in the fondaparinux market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fondaparinux report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the fondaparinux market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The fondaparinux market consists of sales of active pharmaceutical ingredient, injection, and fondaparinux kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fondaparinux Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on fondaparinux market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for fondaparinux ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fondaparinux market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Deep Vein Thrombosis; Pulmonary Embolism
2) By Route of Administration: Oral; Parenteral; Other Routes of Administration
3) By Dosage Form: Injection; Pre-filled Syringe
4) By Distribution Channel : Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End Users: Hospitals; Specialty clinics; Other End Users
Subsegments:
1) By Deep Vein Thrombosis: Prophylaxis (Prevention); Treatment (Management)
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Fondaparinux Market Characteristics
3. Fondaparinux Market Trends And Strategies
4. Fondaparinux Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Fondaparinux Growth Analysis And Strategic Analysis Framework
5.1. Global Fondaparinux PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Fondaparinux Market Growth Rate Analysis
5.4. Global Fondaparinux Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Fondaparinux Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Fondaparinux Total Addressable Market (TAM)
6. Fondaparinux Market Segmentation
6.1. Global Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deep Vein Thrombosis
Pulmonary Embolism
6.2. Global Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Routes of Administration
6.3. Global Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injection
Pre-filled Syringe
6.4. Global Fondaparinux Market, Segmentation By Distribution Channel , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Fondaparinux Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty clinics
Other End Users
6.6. Global Fondaparinux Market, Sub-Segmentation Of Deep Vein Thrombosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prophylaxis (Prevention)
Treatment (Management)
6.7. Global Fondaparinux Market, Sub-Segmentation Of Pulmonary Embolism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Pulmonary Embolism
Chronic Pulmonary Embolism Management
7. Fondaparinux Market Regional And Country Analysis
7.1. Global Fondaparinux Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Fondaparinux Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Fondaparinux Market
8.1. Asia-Pacific Fondaparinux Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Fondaparinux Market
9.1. China Fondaparinux Market Overview
9.2. China Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Fondaparinux Market
10.1. India Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Fondaparinux Market
11.1. Japan Fondaparinux Market Overview
11.2. Japan Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Fondaparinux Market
12.1. Australia Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Fondaparinux Market
13.1. Indonesia Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Fondaparinux Market
14.1. South Korea Fondaparinux Market Overview
14.2. South Korea Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Fondaparinux Market
15.1. Western Europe Fondaparinux Market Overview
15.2. Western Europe Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Fondaparinux Market
16.1. UK Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Fondaparinux Market
17.1. Germany Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Fondaparinux Market
18.1. France Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Fondaparinux Market
19.1. Italy Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Fondaparinux Market
20.1. Spain Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Fondaparinux Market
21.1. Eastern Europe Fondaparinux Market Overview
21.2. Eastern Europe Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Fondaparinux Market
22.1. Russia Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Fondaparinux Market
23.1. North America Fondaparinux Market Overview
23.2. North America Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Fondaparinux Market
24.1. USA Fondaparinux Market Overview
24.2. USA Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Fondaparinux Market
25.1. Canada Fondaparinux Market Overview
25.2. Canada Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Fondaparinux Market
26.1. South America Fondaparinux Market Overview
26.2. South America Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Fondaparinux Market
27.1. Brazil Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Fondaparinux Market
28.1. Middle East Fondaparinux Market Overview
28.2. Middle East Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Fondaparinux Market
29.1. Africa Fondaparinux Market Overview
29.2. Africa Fondaparinux Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Fondaparinux Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Fondaparinux Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Fondaparinux Market Competitive Landscape And Company Profiles
30.1. Fondaparinux Market Competitive Landscape
30.2. Fondaparinux Market Company Profiles
30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
31. Fondaparinux Market Other Major And Innovative Companies
31.1. Sandoz Group AG
31.2. Sun Pharmaceutical Industries Limited
31.3. Jiangsu Hengrui Pharmaceuticals Co. Ltd.
31.4. Cipla Limited
31.5. Aurobindo Pharma Limited
31.6. Dr. Reddy's Laboratories Limited
31.7. Aspen Pharmacare Holdings Limited
31.8. Lupin Pharmaceuticals Inc.
31.9. Zydus Lifesciences Limited
31.10. Sihuan Pharmaceutical Holdings Group Ltd.
31.11. Hefei TNJ Chemical Industry Co. Ltd.
31.12. Apino Pharma Co. Ltd.
31.13. Home Sunshine Pharma Co. Ltd.
31.14. Alchemia Limited
31.15. Zhejiang Borui Pharmaceutical Co. Ltd.
32. Global Fondaparinux Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Fondaparinux Market
34. Recent Developments In The Fondaparinux Market
35. Fondaparinux Market High Potential Countries, Segments and Strategies
35.1 Fondaparinux Market In 2029 - Countries Offering Most New Opportunities
35.2 Fondaparinux Market In 2029 - Segments Offering Most New Opportunities
35.3 Fondaparinux Market In 2029 - Growth Strategies
